✦ LIBER ✦

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

✍ Scribed by Johann Sebastian de Bono; Stephane Oudard; Mustafa Ozguroglu; Steinbjørn Hansen; Jean-Pascal Machiels; Ivo Kocak; Gwenaëlle Gravis; Istvan Bodrogi; Mary J Mackenzie; Liji Shen; Martin Roessner; Sunil Gupta; A Oliver Sartor

Book ID: 117307289
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 293 KB
Volume: 376
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)61389-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Prednisone Plus Cabazitaxel or Mitox

Re: Prednisone Plus Cabazitaxel or Mitoxantrone for Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel Treatment: A Randomised Open-Label Trial

✍ Philippe Beuzeboc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Re: Prednisone Plus Cabazitaxel or Mitox

Re: Prednisone Plus Cabazitaxel or Mitoxantrone for Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel Treatment: A Randomized Open-Label Trial

✍ Dieter Jocham; Martin Sommerauer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Association of Rash With Outcomes in a R

Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer

✍ Mark T. Fleming; Guru Sonpavde; Michael Kolodziej; Sanjay Awasthi; Thomas E. Hut 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 434 KB

Ixabepilone, mitoxantrone, and prednison

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy : A phase 2 study of the department of defense prostate cancer clinical trials consortium

✍ Andrea L. Harzstark; Jonathan E. Rosenberg; Vivian K. Weinberg; Jeremy Sharib; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views